Results 241 to 250 of about 2,344,694 (261)

Targeting the SETD2-FTO-KIT pathway as a pharmacological strategy for TKI-refractory GIST. [PDF]

open access: yesActa Pharm Sin B
Li Z   +17 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors

Annals of Oncology, 2012
Laura Schirosi   +2 more
exaly  

Cobalt oxide species supported on SBA-15, KIT-5 and KIT-6 mesoporous silicas for ethyl acetate total oxidation

Applied Catalysis B: Environmental, 2009
Jessica M. Rosenholm   +2 more
exaly  

Pathologic Stimulus Determines Lineage Commitment of Cardiac C-kit+ Cells

Circulation, 2017
Jop H van Berlo   +2 more
exaly  

Home - About - Disclaimer - Privacy